-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Aridis Pharmaceuticals, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2017 to 2022.
- Aridis Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2023 was -$83K, a 99% increase year-over-year.
- Aridis Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2023 was -$1.14M, a 96.5% increase year-over-year.
- Aridis Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$30.4M, a 28% increase from 2021.
- Aridis Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$42.2M, a 88.9% decline from 2020.
- Aridis Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2020 was -$22.3M, a 24.8% increase from 2019.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)